426 related articles for article (PubMed ID: 30027593)
1. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
3. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review.
Kohle F; Kuwabara S; Lehmann HC
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):473-478. PubMed ID: 33563801
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
[TBL] [Abstract][Full Text] [Related]
6. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Hughes R
J Clin Immunol; 2010 May; 30 Suppl 1():S70-3. PubMed ID: 20393791
[TBL] [Abstract][Full Text] [Related]
7. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
[TBL] [Abstract][Full Text] [Related]
8. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Mathis S; Vallat JM; Magy L
Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
[TBL] [Abstract][Full Text] [Related]
9. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
[TBL] [Abstract][Full Text] [Related]
10. Unconventional treatments for chronic inflammatory demyelinating polyneuropathy.
Rajabally YA
Neurodegener Dis Manag; 2017 Oct; 7(5):331-342. PubMed ID: 29043889
[TBL] [Abstract][Full Text] [Related]
11. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
Franques J
Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
[TBL] [Abstract][Full Text] [Related]
12. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR; Lehmann HC
Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
[TBL] [Abstract][Full Text] [Related]
13. Current treatments for CIDP.
Ropper AH
Neurology; 2003 Apr; 60(8 Suppl 3):S16-22. PubMed ID: 12707418
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
Kaplan A; Brannagan TH
Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
[TBL] [Abstract][Full Text] [Related]
16. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.
Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG
BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085
[TBL] [Abstract][Full Text] [Related]
17. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA
Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
Peltier AC; Donofrio PD
Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]